Novel crystalline form of 2-piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethanesulphonate

摘要

The present invention relates to a novel crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethansulphonate, to processes for its preparation and to its use in agrochemical preparations.

主权项

1. Crystalline form of 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenylmethansulphonate, wherein an X-ray powder diffractogram thereof at 25° C. has at least 3 of the following 2θ (2 theta) values:
2θ=7.75°±0.2 2θ=8.89±0.2 2θ=10.91±0.2 2θ=11.45±0.2 2θ=12.72±0.2 2θ=13.46±0.2 2θ=14.54±0.2 2θ=14.75±0.2 2θ=15.53±0.2 2θ=15.90±0.2 2θ=16.33±0.2 2θ=16.65±0.2 2θ=17.49±0.2 2θ=17.71±0.2 2θ=17.89±0.2 2θ=18.27±0.2 2θ=18.47±0.2 2θ=18.86±0.2 2θ=18.99±0.2 2θ=19.18±0.2 2θ=19.63±0.2 2θ=20.03±0.2 2θ=20.22±0.2 2θ=20.53±0.2 2θ=21.11±0.2 2θ=21.32±0.2 2θ=21.50±0.2 2θ=21.84±0.2 2θ=22.01±0.2 2θ=22.28±0.2 2θ=22.61±0.2 2θ=23.05±0.2 2θ=23.39±0.2 2θ=24.02±0.2 2θ=24.22±0.2 2θ=24.62±0.2 2θ=24.97±0.2 2θ=25.59±0.2 2θ=25.99±0.2 2θ=26.31±0.2 2θ=26.67±0.2 2θ=26.85±0.2 2θ=27.07±0.2 2θ=27.43±0.2 2θ=28.21±0.2 2θ=28.34±0.2 2θ=28.78±0.2 2θ=29.59±0.2 2θ=30.19±0.2 2θ=30.37±0.2 2θ=30.96±0.2 2θ=31.29±0.2 2θ=31.70±0.2 2θ=31.81±0.2 2θ=32.16±0.2 2θ=33.02±0.2 2θ=33.39±0.2 2θ=33.64±0.2 2θ=33.79±0.2 2θ=33.80±0.2 2θ=34.20±0.2 2θ=34.77±0.2 2θ=34.89±0.2 2θ=35.66±0.2 2θ=35.95±0.2 2θ=36.67±0.2 2θ=37.03±0.2 2θ=37.38±0.2 2θ=37.51±0.2 2θ=37.87±0.2